Amgen
Amgen, a California-based multinational biopharmaceutical company, had 2022 revenues in excess of $26 billion. Amgen products include Aranesp, an anemia treatment; Enbrel, used against autoimmune conditions, and Neulasta for chemotherapy patients.
Latest
STAT Plus: Was Amgen less than forthcoming about FDA’s concerns on its cancer drug?
STAT Plus: Pharma industry showers House GOP doctor with campaign cash
STAT Plus: Coherus works with Mark Cuban to sell biosimilar Humira at steep discounts
STAT Plus: In its first tough test, CRISPR epigenome editing cuts cholesterol levels in monkeys
Listen: The FTC v. Amgen, Sarepta’s future, & Galapagos’ turnaround
STAT Plus: Supreme Court rules against Amgen in closely watched case over scope of patent claims
STAT Plus: FTC move to block the Amgen-Horizon deal highlights concerns over negotiations with insurers
All Coverage
advertisement
